B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial
- PMID: 20231532
- DOI: 10.1161/CIRCULATIONAHA.109.904672
B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial
Abstract
Background: In observational studies, hyperhomocysteinemia has been found to be a risk factor for total mortality and cardiovascular events in patients with end-stage renal disease. These patients have grossly elevated homocysteine levels that can be lowered by supplementation with folic acid and vitamin B(12). We conducted a randomized clinical trial with B vitamins to reduce homocysteine levels and therefore cardiovascular events and total mortality.
Methods and results: This randomized, double-blind multicenter study was conducted in 33 dialysis centers in north and east Germany between July 2002 and July 2008. We randomly assigned 650 patients with end-stage renal disease who were undergoing hemodialysis to 2 postdialysis treatments: 5 mg folic acid, 50 microg vitamin B(12), and 20 mg vitamin B(6) (active treatment) or 0.2 mg folic acid, 4 microg vitamin B(12), and 1.0 mg vitamin B(6) (placebo) given 3 times per week for an average of 2 years. The primary outcome was total mortality; the secondary outcome was fatal and nonfatal cardiovascular events. The primary outcome occurred in 102 patients (31%) receiving the active treatment and in 92 (28%) receiving placebo (hazard ratio, 1.13; 95% confidence interval, 0.85 to 1.50; P=0.51). The secondary outcome occurred in 83 patients (25%) receiving the active treatment and in 98 (30%) receiving placebo (hazard ratio, 0.80; 95% confidence interval, 0.60 to 1.07; P=0.13).
Conclusions: Increased intake of folic acid, vitamin B(12), and vitamin B(6) did not reduce total mortality and had no significant effect on the risk of cardiovascular events in patients with end-stage renal disease. Clinical Trial Registration- URL: www.anzctr.org.au. Unique identifier: ACTRN12609000911291. URL: www.cochrane-renal.org. Unique identifier: CRG010600027.
Comment in
-
Homocysteine lowering in end-stage renal disease: is there any cardiovascular benefit?Circulation. 2010 Mar 30;121(12):1379-81. doi: 10.1161/CIR.0b013e3181daa7c9. Epub 2010 Mar 15. Circulation. 2010. PMID: 20231538 Review. No abstract available.
Similar articles
-
Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.Am J Kidney Dis. 2009 Sep;54(3):478-89. doi: 10.1053/j.ajkd.2009.01.266. Epub 2009 Apr 8. Am J Kidney Dis. 2009. PMID: 19359080
-
Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.Hemodial Int. 2007 Apr;11(2):210-6. doi: 10.1111/j.1542-4758.2007.00171.x. Hemodial Int. 2007. PMID: 17403173 Clinical Trial.
-
Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial.J Am Coll Cardiol. 2006 Mar 21;47(6):1108-16. doi: 10.1016/j.jacc.2005.10.064. Epub 2006 Feb 23. J Am Coll Cardiol. 2006. PMID: 16545638 Clinical Trial.
-
Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.Z Kardiol. 2004 Jun;93(6):439-53. doi: 10.1007/s00392-004-0075-3. Z Kardiol. 2004. PMID: 15252738 Review.
-
Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.Semin Thromb Hemost. 2000;26(3):341-8. doi: 10.1055/s-2000-8101. Semin Thromb Hemost. 2000. PMID: 11011852 Review.
Cited by
-
Serum Vitamin B12 Deficiency in Chronic Hemodialysis Patients.Cureus. 2024 Apr 22;16(4):e58751. doi: 10.7759/cureus.58751. eCollection 2024 Apr. Cureus. 2024. PMID: 38779272 Free PMC article.
-
Hyperhomocysteinaemia Promotes Doxorubicin-Induced Cardiotoxicity in Mice.Pharmaceuticals (Basel). 2023 Aug 28;16(9):1212. doi: 10.3390/ph16091212. Pharmaceuticals (Basel). 2023. PMID: 37765020 Free PMC article.
-
Plasma Homocysteine Levels and Cardiovascular Events in Patients With End-Stage Renal Disease: A Systematic Review.Cureus. 2023 Jun 13;15(6):e40357. doi: 10.7759/cureus.40357. eCollection 2023 Jun. Cureus. 2023. PMID: 37456428 Free PMC article. Review.
-
Does Vitamin Supplementation Play a Role in Chronic Kidney Disease?Nutrients. 2023 Jun 23;15(13):2847. doi: 10.3390/nu15132847. Nutrients. 2023. PMID: 37447174 Free PMC article. Review.
-
The Controversial Role of HCY and Vitamin B Deficiency in Cardiovascular Diseases.Nutrients. 2022 Mar 28;14(7):1412. doi: 10.3390/nu14071412. Nutrients. 2022. PMID: 35406025 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical